Efficacy and Safety of Piracetam Taken for 12 Months in Subjects Suffering From Mild Cognitive Impairment (MCI)
Clinical trial NCT00567060 · COMPLETED
Trial details
- NCT number
- NCT00567060
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2000-05-01
- Primary completion
- 2004-01-01
- Enrollment
- 676
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.